search
Back to results

Puberty, Sex Hormones and Pain Sensitivity in Adolescents With Migraine (IHS)

Primary Purpose

Migraine

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Thermal stimuli
Pressure stimuli
Pain ratings
Pressure pain thresholds (PPT)
Conditioned pain modulation (CPM) response
PedMIDAS (Pediatric Migraine Disability Assessment)
Hormonal assessment
Pubertal status
Sponsored by
Washington University School of Medicine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Migraine focused on measuring pain, puberty, sex hormones

Eligibility Criteria

11 Years - 15 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion criteria Age between 11-15 Males and females English speakers Migraine group: diagnosed with migraine Control group: Healthy, with no first degree relative with migraine Exclusion criteria: Pregnancy or breastfeeding, Chronic pain (except for migraine for the migraine group), neurological or psychiatric syndromes or syndromes associated with pubertal maturation Use of medications that impact sex hormone levels (i.e., contraceptive pills)

Sites / Locations

  • Washington University School of MedicineRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

Migraine

Healthy control

Arm Description

Adolescents with a migraine diagnosis

Adolescents without a migraine diagnosis

Outcomes

Primary Outcome Measures

Conditioned pain modulation (CPM) response
This psychophysical test examine the inhibitory pain modulation efficiency. In this test, pressure pain thresholds (measures by kilopascal) are assessed before and during immersion of the foot in cold water.
Sex Hormones
Testosterone levels

Secondary Outcome Measures

Sex hormone assessments
Estrogen levels
Migraine specific measures
Pediatric Migraine Disability Assessment (PedMIDAS) (range 0-540, higher values indicate more disability, with scores >50 considered as severe disability)

Full Information

First Posted
December 6, 2022
Last Updated
August 28, 2023
Sponsor
Washington University School of Medicine
Collaborators
International Headache Society
search

1. Study Identification

Unique Protocol Identification Number
NCT05738213
Brief Title
Puberty, Sex Hormones and Pain Sensitivity in Adolescents With Migraine
Acronym
IHS
Official Title
Hormonal Effects of Puberty-Related Alterations on Pain in Adolescents With Migraine
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
January 10, 2023 (Actual)
Primary Completion Date
January 1, 2025 (Anticipated)
Study Completion Date
January 1, 2028 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Washington University School of Medicine
Collaborators
International Headache Society

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this research study is to investigate the relationships between sex hormone levels and experimental pain sensitivity and migraine severity will be examined.
Detailed Description
This study will investigate how puberty and variability in sex hormone levels impact pain sensitivity and migraine symptoms. Hypothesis 1- A significant reduction in pain sensitivity from early to late pubertal status will be found only for adolescents without but not with migraine during pubertal maturation. Hypothesis 2- Experimental pain sensitivity will be negatively correlated with testosterone levels in adolescents in both groups (with and without migraine). Exploratory Hypothesis 1- In adolescents with migraine, higher migraine severity (headache frequency and migraine disability) will be associated with lower testosterone levels. Exploratory hypothesis 2- Adolescents with migraine will have lower testosterone levels than those without.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Migraine
Keywords
pain, puberty, sex hormones

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Migraine
Arm Type
Active Comparator
Arm Description
Adolescents with a migraine diagnosis
Arm Title
Healthy control
Arm Type
Placebo Comparator
Arm Description
Adolescents without a migraine diagnosis
Intervention Type
Device
Intervention Name(s)
Thermal stimuli
Other Intervention Name(s)
Thermal Sensory Analyzer (TSA-II or PATHWAY platform - Medoc, Ramat Yishai, Israel)
Intervention Description
The Thermal Sensory Analyzer (TSA-II or PATHWAY platform - Medoc, Ramat Yishai, Israel) will be used to safely deliver heat and cold stimuli. These devices can deliver relatively complex stimuli via computer control. All targeted stimulus temperatures will be less than 50°C, and participants will be free to remove their arm or leg at any time from the thermode. Noxious cold stimuli will also be delivered with a plastic water container or a water bath (FISHER, USA). Participants will be free to pull out of the water bath at any time.
Intervention Type
Device
Intervention Name(s)
Pressure stimuli
Other Intervention Name(s)
handheld algometer (Wagner Instruments), the Pressure Algometer (Medoc, Ramat Yishai, Israel)
Intervention Description
Pressure stimuli will be applied by using a handheld algometer (Wagner Instruments) or the Pressure Algometer (Medoc, Ramat Yishai, Israel). These devices have a round probe that allows quantifying the amount of pressure that is being applied. The Pressure Algometer allows a real-time visual feedback to control and monitor applied pressure rates. Pressure will be applied to the lower leg, volar forearm, or trapezius.
Intervention Type
Behavioral
Intervention Name(s)
Pain ratings
Other Intervention Name(s)
Numerical rating scale (ranging from 0- no pain/unpleasantness to- 100 the most intense/unpleasantness pain imaginable), mechanical and computerized visual analog scales (VAS which ranges between ''no pain sensation'' and ''most intense pain imaginable'')
Intervention Description
Pain intensity and pain unpleasantness ratings will be assessed.
Intervention Type
Behavioral
Intervention Name(s)
Pressure pain thresholds (PPT)
Intervention Description
Pressure will be increased continually and participants will be instructed to press a button the first moment they feel pain from the pressure stimulus. The first threshold measurement will be used as a familiarization. The average threshold is calculated from three measurements.
Intervention Type
Behavioral
Intervention Name(s)
Conditioned pain modulation (CPM) response
Intervention Description
The CPM paradigm assesses endogenous inhibitory pain modulation efficiency. CPM testing includes the application of a "test" stimulus without conditioning (control run, pressure pain thresholds) and a subsequent application of the same test stimulus together with a conditioning stimulus (conditioning run, a 60 second of foot immersion in cold water). The CPM response is the difference in the pressure pain thresholds between the control and the conditioning runs.
Intervention Type
Behavioral
Intervention Name(s)
PedMIDAS (Pediatric Migraine Disability Assessment)
Intervention Description
Adolescents with migraine will complete questions regarding their headache frequency. Migraine disability will be assessed using PedMIDAS (Pediatric Migraine Disability Assessment). This self-reported questionnaire assesses the number of days that headaches affect participant's daily activities. This is a widely used, reliable and validated tool to assess migraine disability.
Intervention Type
Diagnostic Test
Intervention Name(s)
Hormonal assessment
Intervention Description
Blood samples (approximetly 2 tablespoons) will be collected for analyses of sex hormone levels (e.g., testosterone, estradiol, progesterone).
Intervention Type
Other
Intervention Name(s)
Pubertal status
Intervention Description
Pubertal status will be assessed using the self-reported Physical Developmental Scale-Wave 3 survey, which allows for differentiation between pre-, early-, late-, and post-pubertal status. Early puberty is defined as a score of 3 and no menarche, mid-puberty is defined as 4 and no menarche, late pubertal is defined as a score of 7 points or less and with menarche, and post pubertal is defined as a score of 8 and menarche. For boys, pubertal maturation status will be determined by the Physical Development Scale using the body hair growth voice change and facial hair questions. Early puberty is defined as a score of 4-5, mid-puberty is defined as a score of 6-8, late pubertal is defined as a score of 9-11 points, and post pubertal is defined as a score of 12.
Primary Outcome Measure Information:
Title
Conditioned pain modulation (CPM) response
Description
This psychophysical test examine the inhibitory pain modulation efficiency. In this test, pressure pain thresholds (measures by kilopascal) are assessed before and during immersion of the foot in cold water.
Time Frame
Baseline
Title
Sex Hormones
Description
Testosterone levels
Time Frame
Baseline
Secondary Outcome Measure Information:
Title
Sex hormone assessments
Description
Estrogen levels
Time Frame
Baseline
Title
Migraine specific measures
Description
Pediatric Migraine Disability Assessment (PedMIDAS) (range 0-540, higher values indicate more disability, with scores >50 considered as severe disability)
Time Frame
Baseline

10. Eligibility

Sex
All
Minimum Age & Unit of Time
11 Years
Maximum Age & Unit of Time
15 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion criteria Age between 11-15 Males and females English speakers Migraine group: diagnosed with migraine Control group: Healthy, with no first degree relative with migraine Exclusion criteria: Pregnancy or breastfeeding, Chronic pain (except for migraine for the migraine group), neurological or psychiatric syndromes or syndromes associated with pubertal maturation Use of medications that impact sex hormone levels (i.e., contraceptive pills)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Alana McMichael, MA
Phone
314-273-6194
Email
amcmich@wustl.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hadas Nahman-Averbuch, PhD
Organizational Affiliation
Washington University School of Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Washington University School of Medicine
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63110
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Joel Brown
Phone
314-273-6194
Email
painlab@wustl.edu

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Puberty, Sex Hormones and Pain Sensitivity in Adolescents With Migraine

We'll reach out to this number within 24 hrs